🇺🇸 FDA

Company profile · Sponsor

Hepion

Hepion Pharmaceuticals

HEPA · NYSE pharma RED BANK, NJ, USA
Pipeline
5
Drugs
0
Patents
1

Quick answer

Hepion (HEPA) is a pharma company. headquartered in RED BANK, NJ, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker HEPA
Exchange NYSE
Company type pharma
Headquarters RED BANK, NJ, USA
SEC CIK 0001583771

Pipeline (5)

Search pipeline →

  1. CRV431 75mg

    Hepion

    NASH - Nonalcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  2. Rencofilstat

    Hepion

    Nonalcoholic Steatohepatitis (NASH)

    phase 2 small molecule active

    1 trial

  3. rencofilstat, 75 mg

    Hepion

    NASH With Fibrosis

    phase 2 small molecule completed

    1 trial

  4. CRV431

    Hepion

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  5. [14C]-rencofilstat 225mg

    Hepion

    NASH With Fibrosis

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 12409206

    Use of cyclosporine analogues for treating fibrosis

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Hepion?

Hepion (HEPA) is a pharma company. headquartered in RED BANK, NJ, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Hepion sponsor?

We track 5 ClinicalTrials.gov-linked programs for Hepion, including CRV431 75mg and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Hepion company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.